Here, we evaluated the clinical implications and prognostic significance of IFN-γ-inducible chemokines by measuring levels of CXCL9, CXCL10, and CXCL11 and their inducer IFN-γ in the peripheral blood of patients with lung cancer. This evidence concerns the gene IFNG and lung cancer.